The report of whole genomic sequencing of the SARS-CoV-2 variants in Sri Lanka was issued on 03.12.2021 by the Allergy, Immunology and Cell Biology Unit of the Department of Immunology Molecular and Molecular Medicine of the University of Sri Jayewardenepura. The study was carried out by USJ researchers including Prof. Neelika Malavige and Dr. Chandima Jeewandara. 94...Read More
Sri Lanka has confirmed a new sub lineage of the Delta strain of SARS-CoV-2, the virus that causes COVID-19, detected in the island and termed B.1.617.2. AY 104. Dr. Chandima Jeewadara, Director, Molecular and Cell Biology Unit of the University of Sri Jayewardenepura (USJ, said Sri Lanka now has three variants that originated in the...Read More
Prof. Neelika Malavige was selected as a member of WHO technical advisory committee on Covid-19. WHO(World Health Organization) has established a Technical Advisory Group (TAG) to advise on scientific, technical and strategic matters related to the COVID-19 Technology Access Pool (C-TAP). The group is composed of 10 renowned experts with a diverse range of knowledge...Read More
The Sinopharm is an inactivated COVID-19 vaccine, which is currently given emergency use authorization by the WHO and is the main vaccine used in many Asian and Middle East Countries. A new study was carried out to determine the kinetics and persistence of immune responses following the Sinopharm/BBIBP-CorV, by investigating the immune responses in a...Read More
Marine xenobiotics (chemical substances that are foreign to animal life) pose a serious threat to marine biodiversity due to their endocrine disrupting effects. Researchers at Centre for Water Quality and Algae Research have detected and quantified, Endocrine disruptor Tributyltin TBT in water, sediment, and biota. “This was the first time TBT contamination in Sri Lankan water,...Read More
USJ researchers including Prof. Neelika Malavige and Dr. Chandima Jeewandara from Allergy Immunology and Cell Biology Unit, Department of Immunology and Molecular Medicine of University of Sri Jayewardenepura have been carrying out sequencing of the SARS-CoV-2 viruses since the onset of the pandemic. With the identification of the delta variant in Sri Lanka, they also detected a...Read More
“The stigma and discrimination experienced by COVID-19 patients in society, workplaces, and healthcare facilities have serious negative consequences in Sri Lanka at both the individual and family levels. In this regard, irresponsible media reporting and sensationalism of news coverage leading to breaching of privacy and confidentiality, defaming and false allegations without consent have been identified...Read More
The report of Whole genomic sequencing of the SARS-CoV-2 variants in Sri Lanka was issued by the Allergy, Immunology and Cell Biology Unit of the Department of Immunology Molecular and Molecular Medicine of the University of Sri Jayewardenepura. The study was carried out by USJ researchers including Prof. Neelika Malavige and Dr. Chandima Jeewandara. Out of...Read More
After investigating the prevalence of different SARS-CoV-2 variants in different provinces in Sri Lanka, USJ researchers found out the Delta variant was responsible for 95.8% of Covid-19 infections in Sri Lanka. It is important to find out the prevalence of different SARS-CoV-2 variants in different provinces in Sri Lanka, to take relevant policy decisions regarding...Read More
USJ researchers have investigated the immune responses of the first dose (rAd26-S) of the Gam-COVID-Vac, which is also known as Sputnik light, in a Sri Lankan population, 4 weeks after receiving the first dose and compared the immune responses with the previously published data following AZD1222, which is another adenovirus vector vaccine. The Gam-COVID-19 first...Read More
